Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice.
Indian J Ophthalmol
;
2006 Jun; 54(2): 133-7
Article
in English
| IMSEAR
| ID: sea-71683
ABSTRACT
Diabetic retinopathy is fast emerging as a leading cause of newly diagnosed legal blindness amongst the working population. Macular edema, as it is commoner, accounts for more vision impairment than neovascular proliferation in diabetic patients. Laser photocoagulation, which is the standard treatment of macular edema, is associated with significant complications and an improvement in visual acuity is unsatisfactory. Intravitreal injection of corticosteroids (especially triamcinolone acetonide) is an emerging treatment modality in the management of diabetic macular edema. This article presents an overview of the principles, technique and complications associated with this procedure.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Vitreous Body
/
Humans
/
Triamcinolone Acetonide
/
Macular Edema
/
Treatment Outcome
/
Diabetic Retinopathy
/
Glucocorticoids
/
Injections
Language:
English
Journal:
Indian J Ophthalmol
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS